Sarcoma: all 1,691 studies

Page 16 of 17. Open to participants first (393), then studies with results posted, then the rest; newest registration first within each.

• Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00064220Phase 2
• Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's SarcomaCompletedNCT00064142Phase 2
• Alanosine in Treating Patients With CancerCompletedNCT00062283Phase 2
• Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell TumorCompletedNCT00062205Phase 2
• Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00061984Phase 3
• Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00061659Phase 2
• Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell TumorCompletedNCT00055952Phase 2
• Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue SarcomaCompletedNCT00053794Phase 2
• Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial SarcomaCompletedNCT00052754Phase 2
• Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue SarcomaCompletedNCT00052390Phase 2
• Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsCompletedNCT00049023Phase 1
• Diagnostic Study of Tumor Characteristics in Patients With Ewing's SarcomaCompletedNCT00048984
• Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverCompletedNCT00041808Phase 1/2
• Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00041249Phase 2
• Exatecan Mesylate in Treating Patients With Advanced Soft Tissue SarcomaCompletedNCT00041236Phase 2
• Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin LymphomaCompletedNCT00040911Not applicable
• Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of ThrombocytopeniaCompletedNCT00038311Phase 3
• Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed MalignanciesCompletedNCT00038207Phase 2
• ABT-751 in Treating Young Patients With Refractory Solid TumorsCompletedNCT00036959Phase 1
• Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving ChemotherapyCompletedNCT00035620Phase 2
• Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable LeiomyosarcomaStatus unknownNCT00033709Phase 2
• Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the UterusTerminatedNCT00033644Phase 2
• Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic CancerCompletedNCT00032162Phase 1/2
• Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone SarcomaCompletedNCT00031915Phase 2
• Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00030784Phase 1
• Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of ChildhoodCompletedNCT00030667Phase 2
• Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyCompletedNCT00030108Phase 1
• Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid TumorsCompletedNCT00028405Phase 1
• Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue SarcomaTerminatedNCT00027911Phase 1
• Bortezomib in Treating Patients With Advanced or Metastatic SarcomaCompletedNCT00027716Phase 2
• Eligibility Screening for the NIH Intramural Research Program Clinical ProtocolsCompletedNCT00026754
• Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United StatesCompletedNCT00026728
• Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone SarcomaStatus unknownNCT00026416Phase 2
• Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal TumorsCompletedNCT00025441Phase 2
• Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the KidneyStatus unknownNCT00025103Phase 2
• BMS-275291 in Treating Patients With HIV-Related Kaposi's SarcomaCompletedNCT00024024Phase 1/2
• Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the SkinTerminatedNCT00023790Phase 1
• Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue SarcomaCompletedNCT00023738Phase 1/2
• Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue SarcomaCompletedNCT00023725Phase 1/2
• BMS-247550 in Treating Patients With Advanced Soft Tissue SarcomaTerminatedNCT00022542Phase 2
• A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's SarcomaTerminatedNCT00020683Phase 2
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's SarcomaStatus unknownNCT00020566Phase 3
• Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00020449Phase 2
• Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00020267Phase 1
• Temozolomide and O6-benzylguanine in Treating Children With Solid TumorsCompletedNCT00020150Phase 1
• Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or LegCompletedNCT00019968Phase 2
• Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNCT00019630Phase 1
• Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV InfectionCompletedNCT00019240Phase 2
• Interleukin-12 in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00019188Phase 1/2
• Thalidomide in Treating Patients With HIV-Associated Kaposi's SarcomaCompletedNCT00019123Phase 2
• CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaStatus unknownNCT00017446Phase 2
• Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent SarcomaWithdrawnNCT00017160Phase 2
• Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00017030Phase 2
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00014456Phase 1
• Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal TumorTerminatedNCT00014313Phase 2
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
• Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid TumorsCompletedNCT00007813Phase 1
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal TumorCompletedNCT00006734Phase 3
• Late Effects of Treatment for Sarcomas in ChildrenCompletedNCT00006515
• STI571 in Treating Patients With Recurrent or Refractory Soft Tissue SarcomaCompletedNCT00006357Phase 1/2
• KSHV Infection in Blood Donors From TexasCompletedNCT00006310
• Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the BoneCompletedNCT00006234Phase 1/2
• EMD 121974 in Treating Patients With HIV-Related Kaposi's SarcomaTerminatedNCT00006222Phase 1
• Effects of Potent Antiretroviral Therapy on Kaposi s SarcomaCompletedNCT00006171
• Thalidomide in Treating Patients With Gynecologic SarcomasCompletedNCT00006005Phase 2
• Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue SarcomaCompletedNCT00005974Phase 2
• Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid TumorsCompletedNCT00005952Phase 1/2
• SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to TreatmentCompletedNCT00005931Phase 2
• Nitrocamptothecin in Treating Patients With Soft Tissue SarcomasCompletedNCT00005874Phase 2
• SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue SarcomasCompletedNCT00005862Phase 2
• Chemotherapy in Treating Patients With Sarcoma of the UterusCompletedNCT00005643Phase 2
• Vaccine Therapy in Treating Patients With Recurrent Soft Tissue SarcomaCompletedNCT00005628Phase 2
• O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue SarcomaCompletedNCT00005066Phase 2
• SU5416 in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00005042Phase 2
• Trastuzumab in Treating Patients With Recurrent OsteosarcomaCompletedNCT00005033Phase 2
• Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive ChemotherapyCompletedNCT00004853Phase 1
• EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaTerminatedNCT00004261Phase 1
• Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By SurgeryCompletedNCT00004250Phase 2
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaCompletedNCT00004241Phase 1
• Rosiglitazone in Treating Patients With LiposarcomaCompletedNCT00004180Phase 2
• Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue SarcomaCompletedNCT00004123Phase 1
• Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue SarcomaCompletedNCT00004109Phase 1
• Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue SarcomaCompletedNCT00004066Phase 2
• Combination Chemotherapy in Treating Patients With Previously Untreated RhabdomyosarcomaCompletedNCT00003958Phase 3
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or SarcomaCompletedNCT00003955Phase 2
• Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue SarcomaCompletedNCT00003939Phase 2
• Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsTerminatedNCT00003926Phase 1
• Genetic Study of Children With Soft Tissue Sarcoma or RhabdomyosarcomaCompletedNCT00003793
• Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue SarcomaCompletedNCT00003778Phase 2
• Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other TumorsCompletedNCT00003750Phase 1
• Chemotherapy in Treating Children With Recurrent or Refractory SarcomasCompletedNCT00003745Phase 2
• SU5416 in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00003720Phase 1
• Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue SarcomaStatus unknownNCT00003719Phase 2
• Temozolomide in Treating Patients With Advanced Soft Tissue SarcomaStatus unknownNCT00003718Phase 2
• Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's SarcomaCompletedNCT00003667Phase 2
• High-dose ICE With AmifostineCompletedNCT00003657Phase 2
• Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial CancerTerminatedNCT00003624Phase 2
• Antineoplaston Therapy in Treating Patients With Soft Tissue SarcomaTerminatedNCT00003521Phase 2
• Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectCompletedNCT00003425Phase 1/2
• Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's SarcomaStatus unknownNCT00003419Phase 2

← Sarcoma overview